Download
s10238-020-00677-6.pdf 670,94KB
WeightNameValue
1000 Titel
  • Zinc as a complementary treatment for cancer patients: a systematic review
1000 Autor/in
  1. Hoppe, C. |
  2. Kutschan, S. |
  3. Dörfler, J. |
  4. Büntzel, J. |
  5. Huebner, Jutta |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-01-26
1000 Erschienen in
1000 Quellenangabe
  • 21(2):297-313
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s10238-020-00677-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053661/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Zinc is a trace element that plays an important role in the immune system and cell growth. The role of zinc in cancer treatment has been discussed for some time, however without reaching an evidenced-based consensus. Therefore, we aim to critically examine and review existing evidence on the role of zinc during cancer treatment. In January 2019, a systematic search was conducted searching five electronic databases (Embase, Cochrane, PsychINFO, CINAHL and PubMed) to find studies concerning the use, effectiveness and potential harm of zinc therapy on cancer patients. Out of initial 5244 search results, 19 publications concerning 23 studies with 1230 patients were included in this systematic review. The patients treated with zinc were mainly diagnosed with head and neck cancer and underwent chemo-, radio- or concurrent radio-chemotherapy. Interventions included the intake of different amounts of zinc supplements and oral zinc rinses. Outcomes (primary endpoints) investigated were mucositis, xerostomia, dysgeusia, pain, weight, dermatitis and oral intake of nutrients. Secondary endpoints were survival data, quality of life assessments and aspects of fatigue, immune responses and toxicities of zinc. The studies were of moderate quality reporting heterogeneous results. Studies have shown a positive impact on the mucositis after radiotherapy. No protection was seen against mucositis after chemotherapy. There was a trend to reduced loss of taste, less dry mouth and oral pain after zinc substitution. No impact was seen on weight, QoL measurements, fatigue, and survival. The risk of side effects from zinc appears to be relatively small. Zinc could be useful in the prevention of oral toxicities during irradiation. It does not help in chemotherapy-induced side effects.
1000 Sacherschließung
lokal Zinc/adverse effects [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Cancer
lokal Aged [MeSH]
lokal Neoplasms/mortality [MeSH]
lokal Dysgeusia/drug therapy [MeSH]
lokal Nutritional supplements
lokal Mucositis/drug therapy [MeSH]
lokal Original Article
lokal Zinc/therapeutic use [MeSH]
lokal Male [MeSH]
lokal Zinc
lokal Immune system
lokal Quality of Life [MeSH]
lokal Neoplasms/psychology [MeSH]
lokal Xerostomia/drug therapy [MeSH]
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Complementary medicine
lokal Adult [MeSH]
lokal Complementary Therapies [MeSH]
lokal Humans [MeSH]
lokal Middle Aged [MeSH]
lokal Neoplasms/drug therapy [MeSH]
lokal Young Adult [MeSH]
lokal Side effects
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SG9wcGUsIEMu|https://frl.publisso.de/adhoc/uri/S3V0c2NoYW4sIFMu|https://frl.publisso.de/adhoc/uri/RMO2cmZsZXIsIEou|https://frl.publisso.de/adhoc/uri/QsO8bnR6ZWwsIEou|https://orcid.org/0000-0003-4931-568X
1000 Hinweis
  • DeepGreen-ID: ccd0f306ff8c4763a35dc2b39039b30b ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6446283.rdf
1000 Erstellt am 2023-04-28T12:42:32.981+0200
1000 Erstellt von 322
1000 beschreibt frl:6446283
1000 Zuletzt bearbeitet 2023-10-20T18:00:14.347+0200
1000 Objekt bearb. Fri Oct 20 18:00:14 CEST 2023
1000 Vgl. frl:6446283
1000 Oai Id
  1. oai:frl.publisso.de:frl:6446283 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source